UK Study Identifies Fentanyl as Highest-Risk Opioid for Fatal Overdose

A large-scale UK study led by researchers at the University of Manchester has found that among opioid painkillers, fentanyl carries the highest risk of respiratory depression, the main cause of fatal overdoses. The study analyzed medical records of 32,909 non-cancer patients treated with opioids in hospitals across northwest England. It revealed that patients using fentanyl were three times more likely to experience respiratory depression compared to those on codeine, and had an 85% higher risk than those on morphine. Other opioids like oxycodone and morphine also showed increased risks compared to codeine. Concurrent use of multiple opioids nearly tripled the risk of life-threatening complications.

Fentanyl’s danger is attributed to its potency and rapid brain penetration, which can abruptly slow breathing. In Israel, fentanyl is approved only for severe oncological or chronic pain. Opioids reduce pain by acting on brain receptors but simultaneously suppress the respiratory center, potentially causing dangerously slow or shallow breathing, low blood oxygen, and carbon dioxide buildup, which can be fatal without immediate intervention.

The study highlighted that patients with chronic obstructive pulmonary disease (COPD) face particularly high risks, with fentanyl users nearly four times more likely to develop respiratory depression than those on codeine. Higher opioid doses correlated with greater risk, and even moderate doses posed increased danger. Combining opioids with gabapentinoids, such as gabapentin or pregabalin, further elevated the risk.

Dr. Magena Gianni, a senior researcher, emphasized that despite these risks, opioids remain essential for managing severe acute pain. She stressed the importance of individualized treatment plans, noting that risks vary by drug type and dosage, underscoring the need for careful patient-specific prescribing.